Hope is not a strategy. Science is.
We guide biotech, pharma, and med-tech from early planning to Phase I–IV execution through NECTAR, our global hub-and-spoke CRO alliance.
Ready to transform your clinical strategy?
Partner in Clinical Success
Manolo Beelke & Partners unites clinical strategy, trial execution, and leadership development. We guide pharma, biotech, and medtech companies from early planning to Phase I–IV operations. Let us help you de-risk and accelerate your clinical programs.
The NECTAR Global Alliance
NECTAR (Networ for Excellence in Clinical Trials And Research) is our hub-and-spoke alliance of CROs and specialist teams. A central medical/quality hub sets strategy and governance; regional partners execute for speed, recruitment and regulatory fit. Result: faster start-up, lower overhead, and consistent GCP across continents.
- Harmonized SOP/QMS
- Co-monitoring & audits
- Global site/country selection
- Rare-disease recruitment
We align clinical plans with financing gates and run NECTAR-enabled execution so your readouts become underwriteable value-inflection points—credible to investors and payers.
From Molecule to Investable Assets
- Clear gates: endpoints and decision trees synced to funding rounds.
- Diligence-ready: protocol/SAP, QA evidence, audit trail, risk register.
- Interim readouts: timing, stats, and data packages built for IC memos.
Guiding Sponsors Through Every Clinical Phase
From indication fit to Phase I–IV operations, we combine protocol craftsmanship with NECTAR’s hub-and-spoke engine for fast start-up, disciplined delivery, and payer-credible data.
- Design that works: inclusion, endpoints, stats payers trust.
- Execution engine: rater QC, country/site selection, timeline control.
- Recruitment reality: capacity & competition model—no wishful thinking.
We develop people who deliver outcomes
Skills, habits, and mindsets that turn clinical strategy into execution—confident decisions, clean communication, disciplined timelines.
